Fibrin Glue Versus Titanium Platelet-rich Fibrin as a Sole Filling Material in Lateral Sinus Lifting With Simultaneous Implant Placement (Randomized Controlled Clinical Trial )
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sinus Floor Augmentation
- Sponsor
- Hams Hamed Abdelrahman
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- change in bone density
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Graftless sinus lift with simultaneous implant placement is one of the new techniques, this new technique is presented based on the physiology of intrasinus bone repair.
Schneiderian membrane is known to have an osteogenic nature, now blood clot can be considered autologous osteogenic graft material, to which osteoprogenitors can migrate, differentiate, and regenerate bone.
The aim of this study is to evaluate the effectiveness of using Fibrin glue versus Titanium platelet rich fibrin (T-PRF) as a sole filling material in lateral sinus lifting using with simultaneous implant placement in comparison to a negative control group.
Investigators
Hams Hamed Abdelrahman
Assistant lecturer of DPH and Clinical statistician
Alexandria University
Eligibility Criteria
Inclusion Criteria
- •Patients requiring implant placement in the posterior maxilla.
- •Tooth extractions at the implant sites were performed at least 4 months before surgery.
- •Residual bone height between the alveolar bone crest and the sinus floor is 3-5 mm
Exclusion Criteria
- •Maxillary sinus pathologies (sinusitis, long-standing nasal obstruction).
- •Any disease-contraindicating surgery (e.g. uncontrolled diabetes).
- •Heavy smokers (smoke greater than or equal 25 cigarettes daily).
- •Acute oral infections.
- •Untreated periodontal disease (gingival index 2 and 3).
- •Poor oral hygiene ( Silness-Löe index (score 2-3) ).
- •A history of radiotherapy or chemotherapy of the head and neck region.
- •Pregnancy.
Outcomes
Primary Outcomes
change in bone density
Time Frame: Baseline and 6 months
bone density will be measured using CBCT
change in implant stability
Time Frame: Baseline and 6 months
implant stability will be measures using Ostell device.
change in vertical bone height
Time Frame: Baseline and 6 months
vertical bone height will be measured using CBCT
Secondary Outcomes
- change in pain intensity(Through 1 week postopertaive)
- Change in edema score(Through 1 week postopertaive)